In the News

Ypso-Facto officially joins the ACCESS project

Ypso-Facto is proud to join officially the ACCESS project (Advanced Cell Control by Spectroscopic Sensors), a French R&D project aiming at improving the production of Advanced Therapy Medicinal products. This project is led by INDATECH – Chauvin Arnoux group, gathers MTInov , StemInov ...

PRESS RELEASE : Ypso-Facto is part of the CALIPSO project led by Sanofi, to disrupt the production of biomedicines!

Supported by Bpifrance, the CALIPSO project aims at developing a new generation of tools that will disrupt industrial bioproduction processes.

Nancy, France, 16 Sept 2021 - Ypso-Facto is proud to play a major role in this challenging and exciting project. With its expertise in bioprocesses and predictive simulation , Ypso-Facto will develop software solutions to support production of innovative therapies. The company will work on three...

CALIPSO: revolutionizing the management of bioproduction processes in healthcare

Paris (France) – September 16th, 2021 – Sanofi, Capgemini, Ypso-Facto, GPC Bio, CEA, CentralSupelec announce the launch of the project CALIPSO !

  A structuring R&D project for French medical research, financed and coordinated by a consortium of high-profile industrial and public actors. An essential mobilisation to accelerate access to new treatments at an acceptable cost, to ensure France’s competitiveness and its health independence...

Introducing the 2021 update of Ypso-Ionic, the software solution for designing chromatographic processes

Including ion exchange, adsorption, affinity, hydrophobic interactions, size exclusion, ion exclusion, chelation...

We are delighted to introduce the latest version of Ypso-Ionic - 2021 edition. Ypso-Ionic is the first commercial application of the Proxima software suite! Maximize the value of your data Embrace the power of mechanistic simulation Open up a new world of opportunities for your chromatographic...

Ypso-Facto invests 1.4M€ in the development of a collaborative software suite for process design and evaluation

The company has received 800k€ from European Regional Development Fund (ERDF) to support the development of Ypso-Proxima®

Nancy, France, January 14th, 2021 - Ypso-Facto, a company specialized in the development and optimization of processes for the Life Sciences Industries invests 1.4M€, including € 800,000 from the European Regional Development Fund (ERDF), to support the development of its software suite Ypso-Proxima®...

New HQ inauguration

Nancy (France), 05 September 2019

We have had the pleasure to open officially our new HQ with our team, partners and local officials. Thank you all for your continuing support! ...